Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials

Lange, N. W., King, K., Husain, S. A., Salerno, D. M., Tsapepas, D. S., Hedvat, J., Yu, M., & Mohan, S. (2024). Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials. American Journal of Transplantation, 24(6), 1027–1034. https://doi.org/10.1016/j.ajt.2024.02.015
Authors:
Nicholas W Lange
Kristen King
Syed Ali Husain
David M Salerno
Demetra S Tsapepas
Jessica Hedvat
Miko Yu
Sumit Mohan
Affiliated Authors:
Nicholas W Lange
Kristen King
Syed Ali Husain
David M Salerno
Demetra S Tsapepas
Jessica Hedvat
Miko Yu
Sumit Mohan
Columbia Affiliation:
Subjects:
Abatacept (MeSH)
Graft Rejection (MeSH)
Kidney Transplantation (MeSH)
Obesity (MeSH)
Immunosuppressive Agents (MeSH)
Graft Survival (MeSH)
Body Mass Index (MeSH)
Author Keywords:
belatacept
kidney transplant
obesity
rejection
elink
Publication Type:
Article
Unique ID:
10.1016/j.ajt.2024.02.015
PMID:
38387620
DOI:
10.1016/j.ajt.2024.02.015
Journal:
American Journal of Transplantation
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: